Your browser doesn't support javascript.
loading
An overview of the first 5 years of the ENIGMA obsessive-compulsive disorder working group: The power of worldwide collaboration.
van den Heuvel, Odile A; Boedhoe, Premika S W; Bertolin, Sara; Bruin, Willem B; Francks, Clyde; Ivanov, Iliyan; Jahanshad, Neda; Kong, Xiang-Zhen; Kwon, Jun Soo; O'Neill, Joseph; Paus, Tomas; Patel, Yash; Piras, Fabrizio; Schmaal, Lianne; Soriano-Mas, Carles; Spalletta, Gianfranco; van Wingen, Guido A; Yun, Je-Yeon; Vriend, Chris; Simpson, H Blair; van Rooij, Daan; Hoexter, Marcelo Q; Hoogman, Martine; Buitelaar, Jan K; Arnold, Paul; Beucke, Jan C; Benedetti, Francesco; Bollettini, Irene; Bose, Anushree; Brennan, Brian P; De Nadai, Alessandro S; Fitzgerald, Kate; Gruner, Patricia; Grünblatt, Edna; Hirano, Yoshiyuki; Huyser, Chaim; James, Anthony; Koch, Kathrin; Kvale, Gerd; Lazaro, Luisa; Lochner, Christine; Marsh, Rachel; Mataix-Cols, David; Morgado, Pedro; Nakamae, Takashi; Nakao, Tomohiro; Narayanaswamy, Janardhanan C; Nurmi, Erika; Pittenger, Christopher; Reddy, Y C Janardhan.
Affiliation
  • van den Heuvel OA; Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Boedhoe PSW; Bergen Center for Brain Plasticity, Haukeland University Hospital, Bergen, Norway.
  • Bertolin S; Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Bruin WB; Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain.
  • Francks C; Department of Psychiatry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Ivanov I; Department of Language & Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
  • Jahanshad N; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
  • Kong XZ; Icahn School of Medicine at Mount Sinai, New York, New York.
  • Kwon JS; Keck USC School of Medicine, Imaging Genetics Center, Mark & Mary Stevens Institute for Neuroimaging & Informatics, Marina del Rey, California.
  • O'Neill J; Department of Language & Genetics, Max Planck Institute for Psycholinguistics, Nijmegen, The Netherlands.
  • Paus T; Department of Psychiatry, Seoul National University College of Medicine, Seoul, South Korea.
  • Patel Y; Department of Brain & Cognitive Sciences, Seoul National University College of Natural Sciences, Seoul, South Korea.
  • Piras F; Division of Child & Adolescent Psychiatry, UCLA Jane & Terry Semel Institute For Neuroscience, Los Angeles, California.
  • Schmaal L; Holland Bloorview Kids Rehabilitation Hospital, Bloorview Research Institute, Toronto, Ontario, Canada.
  • Soriano-Mas C; Holland Bloorview Kids Rehabilitation Hospital, Bloorview Research Institute, Toronto, Ontario, Canada.
  • Spalletta G; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
  • van Wingen GA; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia.
  • Yun JY; Centre for Youth Mental Health, The University of Melbourne, Melbourne, Australia.
  • Vriend C; Department of Psychiatry, Bellvitge University Hospital, Bellvitge Biomedical Research Institute-IDIBELL, Barcelona, Spain.
  • Simpson HB; Centro de Investigación Biomédica en Red de Salud Mental (CIBERSAM), Barcelona, Spain.
  • van Rooij D; Department of Psychobiology and Methodology in Health Sciences, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Hoexter MQ; Laboratory of Neuropsychiatry, IRCCS Santa Lucia Foundation, Rome, Italy.
  • Hoogman M; Division of Neuropsychiatry, Menninger Department of Psychiatry and Behavioral Sciences, Baylor College of Medicine, Houston, Texsas.
  • Buitelaar JK; Department of Psychiatry, Amsterdam Neuroscience, Amsterdam UMC, University of Amsterdam, Amsterdam, The Netherlands.
  • Arnold P; Seoul National University Hospital, Seoul, Republic of Korea.
  • Beucke JC; Yeongeon Student Support Center, Seoul National University College of Medicine, Seoul, Republic of Korea.
  • Benedetti F; Department of Psychiatry, Department of Anatomy & Neurosciences, Amsterdam Neuroscience, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
  • Bollettini I; Center for OC and Related Disorders at the New York State Psychiatric Institute and Columbia University Irving Medical Center, New York, New York.
  • Bose A; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
  • Brennan BP; Departamento e Instituto de Psiquiatria do Hospital das Clinicas, IPQ HCFMUSP, Faculdade de Medicina, Universidade de São Paulo, São Paulo, Brazil.
  • De Nadai AS; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
  • Fitzgerald K; Department of Human Genetics, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Gruner P; Donders Institute for Brain, Cognition and Behaviour, Radboud University, Nijmegen, The Netherlands.
  • Grünblatt E; Mathison Centre for Mental Health Research & Education and Department of Psychiatry, Cumming School of Medicine, University of Calgary, Calgary, Alberta, Canada.
  • Hirano Y; Humboldt-Universität zu Berlin, Department of Psychology, Berlin, Germany.
  • Huyser C; Karolinska Institutet, Department of Clinical Neuroscience, Stockholm, Sweden.
  • James A; Department of Psychiatry and Clinical Psychobiology, Scientific Institute Ospedale, Milan, Italy.
  • Koch K; Department of Psychiatry and Clinical Psychobiology, Scientific Institute Ospedale, Milan, Italy.
  • Kvale G; Obsessive-Compulsive Disorder (OCD) Clinic Department of Psychiatry, National Institute of Mental Health and Neurosciences, Bangalore, India.
  • Lazaro L; McLean Hospital, Harvard Medical School, Belmont, Massachusetts.
  • Lochner C; Department of Psychology, Texas State University, San Marcos, Texas.
  • Marsh R; Department of Psychiatry, University of Michigan Medical School, Ann Arbor, Michigan.
  • Mataix-Cols D; Department of Psychiatry, Yale University, New Haven, Connecticut.
  • Morgado P; Department of Child and Adolescent Psychiatry and Psychotherapy, University Hospital of Psychiatry, University of Zurich, Zurich, Switzerland.
  • Nakamae T; Neuroscience Center Zurich, University of Zurich and ETH Zurich, Zurich, Switzerland.
  • Nakao T; Zurich Center for Integrative Human Physiology, University of Zurich, Zurich, Switzerland.
  • Narayanaswamy JC; Research Center for Child Mental Development, Chiba University, Chiba, Japan.
  • Nurmi E; De Bascule, academic center child and adolescent psychiatry, Amsterdam, The Netherlands.
  • Pittenger C; Department of Psychiatry, University of Oxford, Oxford, UK.
  • Reddy YCJ; Department of Neuroradiology, School of Medicine, Klinikum Rechts der Isar, Technical University of Munich, Munich, Germany.
Hum Brain Mapp ; 43(1): 23-36, 2022 01.
Article de En | MEDLINE | ID: mdl-32154629
ABSTRACT
Neuroimaging has played an important part in advancing our understanding of the neurobiology of obsessive-compulsive disorder (OCD). At the same time, neuroimaging studies of OCD have had notable limitations, including reliance on relatively small samples. International collaborative efforts to increase statistical power by combining samples from across sites have been bolstered by the ENIGMA consortium; this provides specific technical expertise for conducting multi-site analyses, as well as access to a collaborative community of neuroimaging scientists. In this article, we outline the background to, development of, and initial findings from ENIGMA's OCD working group, which currently consists of 47 samples from 34 institutes in 15 countries on 5 continents, with a total sample of 2,323 OCD patients and 2,325 healthy controls. Initial work has focused on studies of cortical thickness and subcortical volumes, structural connectivity, and brain lateralization in children, adolescents and adults with OCD, also including the study on the commonalities and distinctions across different neurodevelopment disorders. Additional work is ongoing, employing machine learning techniques. Findings to date have contributed to the development of neurobiological models of OCD, have provided an important model of global scientific collaboration, and have had a number of clinical implications. Importantly, our work has shed new light on questions about whether structural and functional alterations found in OCD reflect neurodevelopmental changes, effects of the disease process, or medication impacts. We conclude with a summary of ongoing work by ENIGMA-OCD, and a consideration of future directions for neuroimaging research on OCD within and beyond ENIGMA.
Sujet(s)
Mots clés

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Neuroimagerie / Trouble obsessionnel compulsif Type d'étude: Clinical_trials / Overview / Prognostic_studies Limites: Humans Langue: En Journal: Hum Brain Mapp Sujet du journal: CEREBRO Année: 2022 Type de document: Article Pays d'affiliation: Pays-Bas

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Neuroimagerie / Trouble obsessionnel compulsif Type d'étude: Clinical_trials / Overview / Prognostic_studies Limites: Humans Langue: En Journal: Hum Brain Mapp Sujet du journal: CEREBRO Année: 2022 Type de document: Article Pays d'affiliation: Pays-Bas
...